Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Reynolds

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Dose-Response : a Publication of International Hormesis Society|September 30, 2010
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancerAndrew R Reynolds
Angiogenesis|December 23, 2019
Vessel co-option and resistance to anti-angiogenic therapyElizabeth A Kuczynski, Andrew R Reynolds
Angiogenesis|February 1, 2014
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsNaveen S Vasudev, Andrew R Reynolds
The Oncologist|June 3, 2011
Targeting angiogenesis in esophagogastric adenocarcinomaAlicia F C Okines, Andrew R Reynolds, David Cunningham
Trends in Molecular Medicine|January 14, 2003
Nanoparticle-mediated gene delivery to tumour neovasculatureAndrew R Reynolds, S Moein Moghimi, Kairbaan Hodivala-Dilke
Cell and Tissue Research|September 19, 2003
Integrins in angiogenesis: multitalented molecules in a balancing actKairbaan M Hodivala-Dilke, Andrew R Reynolds, Louise E Reynolds
The Journal of Biological Chemistry|January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cellsMorgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Cancer Research|June 2, 2017
Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma <i>In Vivo</i> with Susceptibility Contrast MRISimon P Robinson, Jessica K R Boult, Naveen S Vasudev, et al.
Nature Reviews. Clinical Oncology|March 1, 2019
Vessel co-option in cancerElizabeth A Kuczynski, Peter B Vermeulen, Francesco Pezzella, et al.
Nature Cell Biology|April 30, 2003
EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagationAndrew R Reynolds, Christian Tischer, Peter J Verveer, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Dose-Response : a Publication of International Hormesis Society|September 30, 2010
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancerAndrew R Reynolds
Angiogenesis|December 23, 2019
Vessel co-option and resistance to anti-angiogenic therapyElizabeth A Kuczynski, Andrew R Reynolds
Angiogenesis|February 1, 2014
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsNaveen S Vasudev, Andrew R Reynolds
The Oncologist|June 3, 2011
Targeting angiogenesis in esophagogastric adenocarcinomaAlicia F C Okines, Andrew R Reynolds, David Cunningham
Trends in Molecular Medicine|January 14, 2003
Nanoparticle-mediated gene delivery to tumour neovasculatureAndrew R Reynolds, S Moein Moghimi, Kairbaan Hodivala-Dilke
Cell and Tissue Research|September 19, 2003
Integrins in angiogenesis: multitalented molecules in a balancing actKairbaan M Hodivala-Dilke, Andrew R Reynolds, Louise E Reynolds
The Journal of Biological Chemistry|January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cellsMorgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Cancer Research|June 2, 2017
Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma <i>In Vivo</i> with Susceptibility Contrast MRISimon P Robinson, Jessica K R Boult, Naveen S Vasudev, et al.
Nature Reviews. Clinical Oncology|March 1, 2019
Vessel co-option in cancerElizabeth A Kuczynski, Peter B Vermeulen, Francesco Pezzella, et al.
Nature Cell Biology|April 30, 2003
EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagationAndrew R Reynolds, Christian Tischer, Peter J Verveer, et al.
Pageof 5